{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:42:36Z","timestamp":1787661756544,"version":"build-2736575974"},"reference-count":48,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"Gilead and MSD"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.2217\/fmb-2018-0250","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T10:18:55Z","timestamp":1547547535000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Letermovir for Prophylaxis of Cytomegalovirus Manifestations in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients"],"prefix":"10.1080","volume":"14","author":[{"given":"Sam Van","family":"Hecke","sequence":"first","affiliation":[{"name":"Department of Hematology,University Hospitals Leuven,\rLeuven,\rBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Calcoen","sequence":"additional","affiliation":[{"name":"Clinical Department of Laboratory Medicine,University Hospitals Leuven,\rLeuven,\rBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[{"name":"Clinical Department of Laboratory Medicine,University Hospitals Leuven,\rLeuven,\rBelgium"},{"name":"Department of Microbiology & Immunology,KU Leuven,\rLeuven,\rBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Hematology,University Hospitals Leuven,\rLeuven,\rBelgium"},{"name":"Department of Microbiology & Immunology,KU Leuven,\rLeuven,\rBelgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01202-2"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw668"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.09.004"},{"key":"e_1_3_3_6_1","volume-title":"Human Herpesviruses: Biology, Therapy and Immunoprophylaxis","author":"Griffiths PD","year":"2007","unstructured":"Griffiths PD , BoeckhM . Antiviral therapy for human cytomegalovirus . In : Human Herpesviruses: Biology, Therapy and Immunoprophylaxis . ArvinA , Campadelli-FiumeG , MocarskiE , MoorePS , RoizmanB , WhitleyR , YamanishiK( Eds ) . Cambridge University Press , Cambridge, UK , Chapter 66 ( 2007 )."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000090"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-688432"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00682.x"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00262-15"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303688"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.01.009"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001227"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.905-914.2003"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-121558"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70024-X"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2011.10.011"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00577-06"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2017-0095"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.07.026"},{"key":"e_1_3_3_21_1","unstructured":"European conference on infections in leukaemia . www.ecil-leukaemia.com ."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00289-6"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw370"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.06.006"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.11.038"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.6.2502"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuy004"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01596-09"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-688432"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00922-18"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01623-15"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv352"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016493"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15135"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0389-9"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12483"},{"key":"e_1_3_3_38_1","unstructured":"US Food and Drug Administration . PREVEMYS (letermovir) tablets and PREVEMYS (letermovir)injection . www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/209939Orig1s000 209940Orig1s000TOC.cfm ."},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13292"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13376"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1120"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1094"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.388"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12225"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1309533"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03530.x"},{"key":"e_1_3_3_48_1","first-page":"99","article-title":"Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR","author":"Krawczyk A","year":"2018","unstructured":"Krawczyk A , AckermannJ , GoitowskiBet al. Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR . J. Clin. Virol.99 \u2013 100 , 61 \u2013 66 ( 2018 ).","journal-title":"J. Clin. Virol."},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.06.009"},{"key":"e_1_3_3_50_1","volume-title":"ID Week 2017","author":"Maertens J","year":"2017","unstructured":"Maertens J , SchmittM , MartyFMet al. A mortality analysis of letermovir prophylaxis for cytomegalovirus in CMV seropositive recipients of allogeneic hematopoietic cell transplantation . Presented at : ID Week 2017 . San Diego, CA, USA , 4\u20138 October 2017 ."}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2018-0250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:41Z","timestamp":1719124841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2018-0250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.2217\/fmb-2018-0250"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2018-0250","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}